Smith Karen L.
SEC CIK 1639637 · EDGAR
BoughtSold
Most active insiders at AUPH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TANG KEVIN | Dir | $25.14M | — |
| 2 | Robertson Stephen P. | EVP, GC | — | $546.4K |
| 3 | Cole Ryan | COO | — | — |
| 4 | Keenan Greg | SVP, Chief Medical Off | — | — |
| 5 | Hearne Michael S | CFO | — | — |
| 6 | Miller Joseph M | CFO | — | — |
| 7 | Donley Matthew Maxwell | COO | — | — |
| 8 | Bailey Jeffrey Allen | Dir | — | — |
| 9 | Johnson Craig A | Dir | — | — |
| 10 | Greenleaf Peter | CEO, Dir | — | — |
Smith Karen L. made no open-market trades at AUPH in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-25 | 2024-11-21 | AUPH | Aurinia Pharmaceuticals Inc. | Smith Karen L. | Dir | A - Grant | $0.00 | +12.1K | 24.8K | +96% | $0 |
| D | 2024-11-12 | 2024-11-08 | AUPH | Aurinia Pharmaceuticals Inc. | Smith Karen L. | Dir | M - OptEx | — | +17.9K | 17.9K | New | — |
| D | 2024-11-12 | 2024-11-11 | AUPH | Aurinia Pharmaceuticals Inc. | Smith Karen L. | Dir | S - Sale+OE | $8.43 | -5,241 | 12.7K | -29% | -$44.2K |
| A | 2022-05-27 | 2022-05-19 | QNCX | Quince Therapeutics, Inc. | Smith Karen L. | Chief Medical Off | A - Grant | $0.00 | +170.4K | 194.7K | +700% | $0 |
| D | 2022-05-23 | 2022-05-19 | QNCX | Quince Therapeutics, Inc. | Smith Karen L. | Chief Medical Off | A - Grant | — | +24.3K | 24.3K | New | — |
Purchase Sale Sale after option exercise All abbreviations